Canaccord Genuity analyst Aravinda Galappatthige maintained a Hold rating on BCE (BCE – Research Report) today and set a price target of ...

Canaccord Genuity analyst George Gianarikas reiterated a Buy rating on ASP Isotopes, Inc. (ASPI – Research Report) yesterday and set a price ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of LifeStance Health Group (NasdaqGS:LFST) with a ...

Canaccord Genuity Group Inc. (TSX: CF) (the "Company") today announced a key step in the continued evolution of its strategy related to its U.S. capital markets business, Canaccord Genuity LLC. The ...

TORONTO - Canaccord Genuity Group Inc. has signed a deal to sell its U.S. wholesale market making business to Cantor as part ...

Fintel reports that on April 1, 2025, Canaccord Genuity initiated coverage of Arbe Robotics (NasdaqCM:ARBE) with a Buy ...

This week’s episode features Canaccord Genuity senior investment advisor Cam Currie in conversation with host Adrian ...

MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies ...

Analysts at Canaccord Genuity placed their target price and rating on oilfield services business Wood Group under review on ...

Canaccord Genuity Group said Tuesday that it agreed to sell its U.S. wholesale market-making business as it looks to focus more on its investment-banking platform. The Toronto financial-services firm ...

Sensei Biotherapeutics (Nasdaq: SNSE) is a clinical stage biotechnology company focused on the discovery and development of ...